Alendronate Sodium
NDC 64980-341, Alendronate Sodium, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-341
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090124
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-341 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALENDRONATE SODIUM35 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-341-12 | 64980034112 | 3 BLISTER PACK in 1 CARTON (64980-341-12) / 4 TABLET in 1 BLISTER PACK |
| 64980-341-14 | 64980034114 | 1 BLISTER PACK in 1 CARTON (64980-341-14) / 4 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ffdd2496-d253-419b-85a6-8c615f7545f1NADAC price for package 64980034114
GET /v1/drugs/nadac/64980034114
Use it
Look up 64980-341 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-341 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-341. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.